U01AA027997
Cooperative Agreement
Overview
Grant Description
Fructokinase inhibitors for the treatment of alcohol use disorder.
Awardee
Funding Goals
TO DEVELOP A SOUND FUNDAMENTAL KNOWLEDGE BASE WHICH CAN BE APPLIED TO THE DEVELOPMENT OF IMPROVED METHODS OF TREATMENT AND MORE EFFECTIVE STRATEGIES FOR PREVENTING ALCOHOLISM AND ALCOHOL-RELATED PROBLEMS. THE NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM (NIAAA) SUPPORTS RESEARCH IN A BROAD RANGE OF DISCIPLINES AND SUBJECT AREAS RELATED TO BIOMEDICAL AND GENETIC FACTORS, PSYCHOLOGICAL AND ENVIRONMENTAL FACTORS, ALCOHOL-RELATED PROBLEMS AND MEDICAL DISORDERS, HEALTH SERVICES RESEARCH, AND PREVENTION AND TREATMENT RESEARCH. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION AND TECHNOLOGY TRANSFER THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Colorado
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 06/30/24 to 12/31/25 and the total obligations have increased 372% from $1,293,692 to $6,102,731.
Colorado Research Partners was awarded
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder
Cooperative Agreement U01AA027997
worth $6,102,731
from National Institute on Alcohol Abuse and Alcoholism in September 2019 with work to be completed primarily in Colorado United States.
The grant
has a duration of 6 years 3 months and
was awarded through assistance program 93.273 Alcohol Research Programs.
The Cooperative Agreement was awarded through grant opportunity Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 9/5/25
Period of Performance
9/23/19
Start Date
12/31/25
End Date
Funding Split
$6.1M
Federal Obligation
$0.0
Non-Federal Obligation
$6.1M
Total Obligated
Activity Timeline
Transaction History
Modifications to U01AA027997
Additional Detail
Award ID FAIN
U01AA027997
SAI Number
U01AA027997-4026821438
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Small Business
Awarding Office
75N500 NIH National Institute on Alcohol Abuse and Alcoholism
Funding Office
75N500 NIH National Institute on Alcohol Abuse and Alcoholism
Awardee UEI
KBGTNMR2H497
Awardee CAGE
72T90
Performance District
CO-90
Senators
Michael Bennet
John Hickenlooper
John Hickenlooper
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Health and Human Services (075-0894) | Health research and training | Grants, subsidies, and contributions (41.0) | $6,163,104 | 100% |
Modified: 9/5/25